References
- Pressman D, Day E D, Blau M. The use of paired labelling in the determination of tumour-localising antibodies. Cancer Res 1957; 17: 845–50
- Pressman D, Korngold L. The in vivo localisation of anti-Wayne-osteogenic sarcoma antibody. Cancer 1957; 6: 619–23
- Day E D, Lassiter S, Woodhall B, Mahaley J L, Mahaley M S. The localisation of radioantibodies in human brain tumours 1. Preliminary exploration. Cancer Res 1965; 25: 773–8
- Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7
- Mach J-P, Buchegger F, Fomi M, Ritschard J, Berche C, Lumbroso J-D, Schreyer M, Girardet C, Accolla R S, Carrel S. Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 1981; 2: 239–49
- Epenetos A A, Mather S, Granowska M, Nimmon C C, Hawkins I R, Britton K E, Shepherd J, Taylor-Papa-dimitrkm J, Durbin H, Malpas J S, Bodmer W F. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet 1982; 2: 999–1004
- Larson S M, Carrasquillo J A, Krohn K A, Brown J P, McGuffin R W, Ferens J M, Graham M M, Hill L D, Beaumier P L, Hellstrom K E, Hellstrom I. Localisation of l31I-labelled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 1983; 72: 2101–14
- Goldman A, Vivian G, Gordon I, Pritchard J, Kem-shead J. Immunolocalisation of neuroblastoma using radiolabelled monoclonal antibody UJ13A. J Pediatr 1984; 105: 252–65
- Phillips J, Alderson T, Sikora K, Watson J. Localisation of malignant glioma by a radiolabelled human monoclonal antibody. J Neurol Neurosurg Psychiatry 1983; 46: 388–92
- Richardson R B, Davies A G, Bourne S P, Staddon G E, Jones D H, Kemshead J T, Coakham H B. Radioimmu-nolocalisation of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A. Eur J Nucl Med 1986; 12: 313–20
- Kemshead J T, Goldman A, Jones D, Pritchard J, Malpas J S, Gordon I, Hurley G D, Breatnach F. Therapeutic application of radiolabelled UJ13A in children with disseminated neuroblastoma–a phase I study. Advances in Neuroblastoma Research, A E Evans, G T D'Angio, R C Seeger, A E Liss. Raven Press, New York 1985; 533–44
- Courtenay-Luck N, Epenetos A A, Hainan K E, Hooker G, Hughes J MB, Krausz T, Lambert J, Lavender P, MacGregor W G, McKenzie C J, Munro A, Myers J, Orr J S, Pearse E E, Snook D, Webb B, Burchell j, Durbin H, Kemshead J T, Taylor-Papadimitriou J. Antibody-guided irradiation of three cases illustrating a new method of treatment. Lancet 1984; 1: 1441–3
- Epenetos A A, Courtenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender J P, McKenzie C G. Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J 1985; 290: 1463–6
- Bramlet D, Gilberti B A, Bender J. Meningeal carcinomatosis: case report and review of the literature. Neurology 1976; 26: 287–90
- Coakham H B, Garson J A, Allan P M, Harper E I, Brownell B, Kemshead J T, Lane E B. Immunochisto-logical diagnosis of central nervous system tumours using a monoclonal antibody panel. J Clin Pathol 1985; 38: 165–73
- Bourne S P, Coakham H B, Kemshead J T, Brownell B, Davies A G. The role of monoclonal antibodies in the diagnosis and characterisation of medulloblastoma. Medulloblastoma in Children: new concepts in tumour biology, diagnosis and treatment, P M Zeltzer, C Pochedly. Praeger, New York 1986
- Taylor-Papadimitriou J, Paterson J A, Arklie J, Burchell J, Ceriani R L, Bodmer W F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1981; 28: 17–21
- Hunter W M, Greenwood F C. Preparation of iodine-131 labelled growth hormone of high specific activity. Nature 1962; 194: 495–6
- Coakham H B, Garson J A, Brownell B, Allan P M, Harper E I, Lane E B, Kemshead J T. Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet 1984; i: 1095–8
- Davies A G, Richardson R B, Bourne S P, Kemshead J T, Coakham H B. Immunolocalisation of brain tumous. Tumours of the Brain, N Bleehan. Springer-Verlag. 1985; 83–100
- Buchegger F, Haskell C H, Schreyer M, Scazziga B R, Randin S, Carrell S, Mach J P. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localisation of human colon carcinoma grafted into nude mice. J Exp Med 1983; 158: 413–27
- Chou S N, Aust J B, Moore G E, Peyton W T. Radioactive iodinated human serum albumin as tracer agent for diagnosing and localising intracranial lesions. Proc Soc Exp Biol Med 1951; 77: 193–5
- Fuller L GA, Rogoff E, Deck M, Galicich J, Ghavimi F, Levitt S, Smith Ch E, D'Angio G J. Recent experience with intrathecal radiogold for medulloblastoma and ependymoblastoma: a progress report. Am J Radiol 1974; 122: 75–9
- Smith P H, Thomas R P, Steel H A, Beaty H E, Dawson K B, Peckham M J. Therapeutic irradiation of the central nervous system using intrathecal 90Y-DPTA. Br J Radiol 1976; 49: 141–7
- Lashford L S, Davies A G, Richardson R B, Bourne S P, BuUimore J A, Eckert H, Kemshead J T, Coakham H B. A pilot study of 13II monoclonal antibodies in the therapy of leptomeningeal tumours. Cancer 1988; 61: 857–68
- Brown I H, Lee T J, Eden O B, BuUimore J A, Savage D CL. Growth and endocrine function after treatment for medulloblastoma. Archiv Dis Child 1983; 58: 722–7
- Silverman C L, Palkes H, Talent B, Kovnar E, Clouse J W, Thomas P RM. Late effects of radiotherapy on patients with cerebellar medulloblastoma. Cancer 1984; 54: 825–9